Molly OhAinleStaff Scientist Started 6/14 B.S., UC-Davis Ph.D., University of Washington Postdoc, UC-Berkeley firstname.lastname@example.org
Area of Interest: Novel lentiviral restriction factors
Ferdinand RoeschPostdoctoral Research Associate Started 9/14 M.S., Universite Denis Diderot (France) Ph.D., Universite Denis Diderot (France) email@example.com
Area of Interest: Molecular mechanisms of HIV
Nicholas ChesarinoPostdoctoral Research Associate Started 1/17 STD/AIDS Research Training Fellowship B.S., John Carroll University Ph.D., The Ohio State University firstname.lastname@example.org
Area of Interest: Cellular and molecular mechanisms of viral restriction
Rossana Colon-ThilletGraduate Student Jointly Mentored with Harmit Malik Started 6/15 B.S., University of Puerto Rico-Cayey UW/FHCRC Interdisciplinary Ph.D. program in MCB email@example.com
Area of Interest: Broadly acting host antiviral genes
Erin GarciaGraduate Student Started 4/15 B.S., New Mexico State University UW Ph.D. program in Microbiology firstname.lastname@example.org
Area of Interest: APOBEC3H function and evolution
Mollie McDonnellGraduate Student NSF Graduate Research Fellowship Started 9/16 B.S., Rice University UW/FHCRC Interdisciplinary Ph.D. program in MCB email@example.com
Area of Interest: Molecular mechanisms of HIV antiviral proteins
Abby FeltonResearch Tech II Started 8/17 B.S., Biology, Kent State University firstname.lastname@example.org
Louisa PendergastResearch Tech I Started 5/16 B.S., Carnegie Mellon University email@example.com
Area of Interest: Cellular engineering and regenerative therapies
Carol Deminie, Ph.D.
11/90-7/94 Subject: Replication and assembly of chimeric retroviruses. Currently, Research Associate at Yale Cancer Research Center, New Haven, CT.
Paul Lewis, M.D.
8/91-8/93 Pediatric Infectious Disease Fellow; Subject: HIV infection of non-dividing cells. Currently, Associate Professor, Oregon Health Sciences University and Clackamas County Health Officer, Portland, OR.
Peter Gallombardo, Ph.D.
7/93-4/95 Subject: HIV-2 replication in non-dividing cells; deceased 8/95.
Wei-Chun Goh, M.D., Ph.D.
7/93-1/03 Infectious Disease Fellow; Subjects: Biochemical analysis of Vpr and genetic analysis of an exposed HIV seronegative cohort. Currently, Staff Physician, Internal Medicine/Infectious Diseases, Martinez, CA.
Steven Bartz, Ph.D.
2/95-7/01 Subject: Mechanisms of HIV-induced protection from apoptosis and induction of apoptosis. Currently, Director, Worldwide Licensing at Merck, San Francisco, CA.
Marie Vodicka, Ph.D.
6/95-8/02 Subject: Intracellular trafficking of HIV. Currently, Regulatory Affairs Director at Hogan Lovells, Washington, DC.
Rahm Gummuluru, Ph.D.
11/96-12/02 Subject: Mechanisms of HIV transmission between cells. Currently, Associate Professor, Department of Microbiology, Boston University Medical School, Boston, MA.
Aleida Perez, Ph.D.
11/98-10/00 Subject: Role of HIV infection of non-dividing cells. Currently, Staff Scientist, Office of Educational Programs, Brookhaven National Laboratory, Long Island, NY.
Timothy Dellit, M.D.
6/02-6/03 Infectious Disease Fellow; Subject: HIV population biology. Currently, Professor of Medicine, Associate Dean of Clinical Affairs, Associate Medical Director, Harborview Medical Center; University of Washington, Seattle, WA.
Sara L. Sawyer, Ph.D.
9/03-12/07 Joint mentorship with Harmit Malik. Subject: Molecular evolution of host restriction factors. Currently, Associate Professor, BioFrontiers Institute, Department of MCDB, University of Colorado-Boulder, Boulder, CO.
Yegor Voronin, Ph.D.
10/03-12/08 Subject: HIV Population Biology. Currently, Senior Scientific Officer, Global HIV Vaccine Enterprise, New York, NY.
Masahiro Yamashita, Ph.D.
4/01-9/09 Subject: Role of Capsid in HIV infection of non-dividing cells. Currently, Assistant Professor, Aaron Diamond Aids Reseach Center, New York, NY.
Lucie Etienne, Ph.D.
1/12-12/14 Subject: Adaptation of lentiviruses to hominoids. Currently, Assistant Professor (CR2, CNRS) at the International Center of Infectiology Research, CIRI, Lyon, France.
Oliver Fregoso, Ph.D.
4/11-3/16 Subject: Functions of Vpr. Currently, Assistant Professor, Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, CA.
Jolien Vermeire, Ph.D.
6/15-9/16 Subject: Lentiviral restriction by interferon-stimulated genes. Currently, Research Scientist, Ghent University Hospital, Ghent, Belgium.
6/90-6/96 Ph.D. in MCB and Microbiology Programs; Thesis title: Functional Analyses of Virion Associated Proteins Encoded by Immunosuppressive Retroviruses. Currently, Chief, Model Development Section, NCI-Frederick Cancer Research and Development, Frederick, MD.
8/94-8/99 Ph.D. in MCB program; Thesis Title: Evolution of Vpr function in Primate Lentiviruses. Currently, Attorney-at-Law
8/96-12/02 Ph.D. in MSTP program (joint with Ake Lernmark at Dept. of Medicine, UW); Thesis Title: The role of AU repeats in the CTLA-4 gene in Type I Diabetes Susceptibility. Currently, Director, Juvenile Arthritis and Rheumatology Care and Research Center, Las Vegas, NV.
8/00-8/01 D.E.A. before returning to graduate school with Marc Sitbon in Montpellier, France. Project; Biochemical analysis of Vpr/Vpx. Currently, Team Leader, DR2 INSERM, Institut Curie, Paris, France.
6/02-12/06 Ph.D. in MCB program; Thesis Title: Control of Retroviral Replication by Host Cell Factors. Currently, Principal Scientist, Celgene, Seattle, WA
8/03-12/07 Ph.D. in MCB program; Thesis Title: Adaptive Evolution and Loss of Function of a Primate Intrinsic Immunity Gene. Currently, Staff Scientist, Emerman Lab, FHCRC, Seattle, WA.
6/04-8/09 Ph.D. in Pathobiology program; Thesis Title: Functional Interaction of Primate Lentiviral Capsid with Host Factors. Currently, Scientist II, Immune Design, Seattle, WA.
6/05-5/10 Ph.D. in MCB program; Thesis Title: Molecular Consequences of Virus-Host Interactions as Inferred by the Function and Evolution of Host Antiviral Protein Trim5alpha. Currently, Director, Gene Engineering & Delivery, Juno Therapeutics, Seattle, WA.
6/07-6/11 Ph.D. in Microbiology; Thesis Title: Functional Consequences of Polymorphisms Found in a Human Antiviral Gene. Currently, Assistant Professor, Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, CA.
6/08-2/12 Ph.D. in Microbiology; Thesis Title: fundmentals of the host-virus evolutionary arms race. Currently, Assistant Professor, School of Life Sciences, Arizona State University, Tempe, AZ.
6/08-9/12 Ph.D. in MCB program; Thesis Title: The Ancient and Recurrent Evolution of Apobec3 Antiviral Activity in Primate. Currently, Assistant Professor, Department of Biomedical Sciences & Pathology, Virginia Tech University, Blacksburg, VA.
6/08-2/13. Joint Mentorship with Harmit Malik, Ph.D. in Genome Sciences program; Thesis Title: Learning from the past: Searching for novel TRIM, CypA, and TIMCyp antiviral factors in humans. Currently, TRIO McNair Project Coordinator, Undergraduate Studies, Cal State San Marcos, San Marcos, CA.
6/09-12/12 Ph.D. in MCB program; Thesis Title: Virus-driven evolution of an antiviral gene in deep and shallow time. Currently, Investigator, HIV DRP Retroviral Replication Laboratory, NCI/CCR, Frederick, MA.
6/10-1/15 . Joint Mentorship with Harmit Malik, Ph.D. in MCB program; Thesis Title: Evolution of antiviral breadth in Mx GTPases. Currently, Postdoctoral Fellow, UC-Berkeley, Berkeley, CA.
6/13-6/16 . Ph.D. in MCB program; Thesis Title: The evolutionary history and activity of a gain-of-function polymorphism in a human antiviral gene . Currently, Patent Agent, Lee & Hayes, Seattle, WA.